Vol 2, No 4 (2013)

Date published: 2013-09-03

Table of Contents

open access

President’s voice

Prezes ma głos

Leszek Czupryniak


Diabetologia Kliniczna 2013;2(4):113.
Original articles (submitted)

Gender differences in adaptation to insulin therapy in type 2 diabetes

Zuzanna Kwissa-Gajewska, Aleksandra Kroemeke

Research paper

Diabetologia Kliniczna 2013;2(4):115-119.

Metformin — new reimbursement indications

Krzysztof Strojek, Marta Wróbel, Aleksandra Szymborska-Kajanek, Dominika Rokicka

Review paper

Diabetologia Kliniczna 2013;2(4):120-124.

Metformin and AMP-activated protein kinase and energetic processes

Katarzyna Nabrdalik, Edyta Cichocka, Janusz Gumprecht

Review paper

Diabetologia Kliniczna 2013;2(4):125-130.

Reversibility of diabetic nephropathy

Alicja Milczarczyk, Edward Franek

Review paper

Diabetologia Kliniczna 2013;2(4):131-135.

The role of melatonin in type 2 diabetes mellitus

Melania Mikołajczyk

Review paper

Diabetologia Kliniczna 2013;2(4):136-143.
Pharmaceutical news

A guide to using Novo Nordisk insulin analogues in patients with type 2 diabetes

Piotr Fichna, Edward Franek, Grzegorz Gajos, Janusz Gumprecht, Teresa Koblik, Adam Krętowski, Maciej Małecki, Ewa Wender-Ożegowska, Bogumił Wolnik, Dorota Zozulińska-Ziółkiewicz

Other materials agreed with the Editors

Diabetologia Kliniczna 2013;2(4):150-157.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.


Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl